Despite a push from some Indiana legislators to legalize marijuana as an alternative to opioid pain medications, government officials — including the state’s governor himself — say they won’t support efforts to legalize medical pot.

On an afternoon in August at the Indiana State Library, a stately limestone building usually home to genealogy conventions or history lectures, the Indiana chapter of The National Organization for the Reform of Marijuana Laws, or NORML, laid out a very distinctive welcome mat emblazoned with a familiar leafy plant.

The American Legion of Indiana passed a resolution Sunday calling on Congress to recognize marijuana as a drug with medical value and asking Indiana legislatures to develop a medical marijuana program.

High out-of-pocket costs may prove to be an insurmountable obstacle for patients seeking medical marijuana. While the treatment has been legalized, the state has not set a price for it, and insurance companies will not be covering it.

One would think that with medical marijuana now legal in 23 states, the science to support its efficacy would be fairly definitive. Surprisingly, that's not the case.

Despite the fierce political tussles and competing medical claims the truth is this: Very little solid scientific evidence exists to either confirm or dispute marijuana’s effectiveness as a drug or its potential for harm.

People who buy medical marijuana products might not be getting what they paid for, a study finds. And evidence remains elusive on benefits for most medical conditions, even though almost half the states have legalized medical marijuana.

Recreational marijuana has been legalized in four states, but that doesn't mean it's a tested consumer product. Some of those potent buds are covered in fungus while others contain traces of butane, according to an analysis of marijuana in Colorado.